WallStreetZenWallStreetZen

AnalystsJulian Harrison
Julian Harrison's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 14%
#582 out of 4174 analysts
Average Return
+32.18%
Win Rate
67%8 out of 12
Risk vs Reward
Poor
Good

Julian Harrison's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prometheus Biosciences IncRXDX
+150.15%$43.05$107.69
2022-02-10 -
2023-02-06
Strong Buy
Aerovate Therapeutics IncAVTE
+116.12%$10.30$22.26
2022-02-10 -
2022-08-16
Strong Buy
Prometheus Biosciences IncRXDX
+79.48%$60.00$107.69
2022-10-02 -
2023-02-06
Strong Buy
Keros Therapeutics IncKROS
+76.82%$31.79$56.21
2022-07-25 -
2023-02-06
Strong Buy
Aerovate Therapeutics IncAVTE
+38.66%$18.03$25.00
2022-12-05 -
2023-02-06
Strong Buy

Julian Harrison's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Keros Therapeutics IncKROS
2Strong Buy$105.00+86.80%Maintains
2 months ago
Prometheus Biosciences IncRXDX
3Strong Buy$181.00+68.08%Maintains
2 months ago
Aerovate Therapeutics IncAVTE
3Strong Buy$27.00+8.00%Upgrades
2 months ago
Outlook Therapeutics IncOTLK
1Strong Buy$7.00+455.56%Initiates Coverage On
3 months ago
Aclaris Therapeutics IncACRS
1Strong Buy$32.00+133.07%Initiates Coverage On
4 months ago
Liquidia CorpLQDA
1Strong Buy$17.00+146.38%Maintains
7 months ago
Biora Therapeutics IncBIOR
1Strong Buy$4.00-1.48%Assumes
9 months ago
United Therapeutics CorpUTHR
1HoldN/AN/AInitiates Coverage On
a year ago
Morphic Holding IncMORF
1Strong Buy$64.00+81.41%Initiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.